Sawai Group Holdings Co., Ltd. (TYO:4887)

Market Cap	223.51B
Revenue (ttm)	194.21B
Net Income (ttm)	12.34B
Shares Out	115.45M
EPS (ttm)	102.53
PE Ratio	16.72
Forward PE	12.32
Dividend	55.00 (2.84%)
Ex-Dividend Date	Sep 29, 2025

Volume	314,700
Average Volume	321,130
Open	1,982.50
Previous Close	2,001.00
Day's Range	1,935.50 - 1,993.50
52-Week Range	1,650.00 - 2,250.00
Beta	-0.06
RSI	43.16
Earnings Date	Nov 14, 2025

About Sawai Group Holdings

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms for various therapeutic areas comprising cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital organs and...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 3,310
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4887

Financial Performance

In 2024, Sawai Group Holdings's revenue was 189.02 billion, an increase of 6.88% compared to the previous year's 176.86 billion. Earnings were 11.97 billion, a decrease of -12.60%.